Yahoo Web Search

  1. Yahoo Finance Results

  2. Why AbbVie Inc.'s Shares Rocketed 16% in January

    Motley Fool via Yahoo FinanceFeb 07 13:00 PM

    After updating investors on its 2017 financial performance and providing a bullish outlook for its future, shares in AbbVie Inc. (NYSE: ABBV) rallied by 16% in January, according ...

  3. Short interest is extremely low for ABBV with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ABBV ...

    118.60+3.70 (+3.22%)

    at Fri, Feb 16, 2018, 4:00PM EST - U.S. Markets close in 1 hr 29 mins

    After Hours 118.62 +0.02 (+0.02%)

    Delayed Quote

    • Open 115.23
    • High 119.20
    • Low 115.20
    • Prev. Close 114.90
    • 52 Wk. High 125.86
    • 52 Wk. Low 61.30
    • P/E 35.94
    • Mkt. Cap 189.34B
  4. Is AbbVie Inc’s (NYSE:ABBV) ROE Of 93.77% Sustainable?

    Simply Wall St. via Yahoo FinanceFeb 12 6:05 AM

    With an ROE of 93.77%, AbbVie Inc (NYSE:ABBV) outpaced its own industry which delivered a less exciting 16.06% over the past year. While the impressive ratio tells us that ABBV ...

  5. 3 Big Biotech Stocks With Major Catalysts on the Way

    Motley Fool via Yahoo FinanceJan 30 13:04 PM

    Once a company grows to the size of AbbVie Inc. (NYSE: ABBV), Celgene Corporation (NASDAQ: CELG), or Gilead Sciences, Inc. (NASDAQ: GILD), moving the needle forward gets ...

  6. AbbVie Shares Double In A Year; Leerink Moves To Sidelines

    Benzinga via Yahoo FinanceJan 29 20:51 PM

    AbbVie Inc (NYSE: ABBV) shares ran up about 14 percent last Friday following the release of fiscal fourth-quarter results, where it revealed expectations for higher earnings and ...

  7. Meanwhile, earnings results were in focus with AbbVie ABBV reporting a strong quarter and providing an upbeat outlook for 2018. A Look at Q4 Earnings Results: Companies like Celgene CELG ...

  8. Stocks recently featured in the blog include Sanofi SNY, Seattle Genetics SGEN, AbbVie ABBV, Celgene CELG and Vertex VRTX. Acquisitions once again remained in focus this week with Ablynx ...

  9. Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View

    Zacks via Yahoo FinanceJan 31 14:25 PM

    Anthem Inc.’s ANTM fourth-quarter 2017 adjusted net income per share of $1.29 surpassed the Zacks Consensus Estimate of $1.25 by 3.2%. Operating revenues of $22.4 billion surpassed the ...

  10. Will Gilead (GILD) Disappoint Investors in Q4 Earnings?

    Zacks via Yahoo FinanceFeb 01 13:40 PM

    Gilead Sciences Inc. GILD, is scheduled to report fourth-quarter results on Feb 6, after the market closes. Gilead, a leader in the hepatitis C virus (“HCV”) space, has a mixed track ...

  11. FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up

    Zacks via Yahoo FinanceFeb 08 14:36 PM

    Gilead Sciences, Inc. GILD received a major boost when the FDA approved the company’s once-daily single tablet regimen (“STR”), Biktarvy (bictegravir...’s HIV franchise. The HCV franchise ...

  1. Ad
    related to AbbVie Inc